Does SOMATOSTATIN Cause Malignant neoplasm progression? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Malignant neoplasm progression have been filed in association with SOMATOSTATIN. This represents 12.2% of all adverse event reports for SOMATOSTATIN.
12
Reports of Malignant neoplasm progression with SOMATOSTATIN
12.2%
of all SOMATOSTATIN reports
3
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SOMATOSTATIN?
Of the 12 reports, 3 (25.0%) resulted in death, 2 (16.7%) required hospitalization, and 3 (25.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOMATOSTATIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does SOMATOSTATIN Cause?
Drug ineffective (12)
Condition aggravated (11)
Off label use (11)
Gastrointestinal haemorrhage (10)
Gastric varices (9)
Portal hypertension (9)
Hypersensitivity (8)
Product use in unapproved indication (8)
Anxiety (7)
Cholelithiasis (7)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)